KAT8 Promotes the Resistance of Human NSCLC Cells to Mir-7 Intervention Via the H4K16/PAX6 Axis

Jing Yang,Xu Zhao,Dongmei Li,Lin Tang,Wen Zheng,Longqinq Chen,Jing Chen,Chao Chen,Ming Qin,Mengmeng Guo,Ya Zhou,Juanjuan Zhao,Zhixu He,Lin Xu

DOI: https://doi.org/10.21203/rs.3.rs-1663961/v1

2022-01-01

Abstract:Abstract BackgroundAccumulating evidence has shown that microRNAs (miRNAs), one of the representative types of noncoding RNAs (ncRNAs), contribute to the development of non-small-cell lung cancer (NSCLC) and act as promising therapeutic targets in NSCLC. However, how to improve the efficiency of miRNA-based gene intervention against NSCLC remains largely unknown.MethodsA proliferation assay was used to assess the effect of miR-7 intervention on human NSCLC cells. RNA-seq was performed to analyze the global gene expression of miR-7-resistant cells. Mechanistically, coimmunoprecipitation (Co-IP), chromatin immunoprecipitation-polymerase chain reaction (ChIP-PCR) and western blotting were performed.ResultsUnder continuous intervention with miR-7, miR-7 levels in human NSCLC cells steadily increased, while its inhibition efficiency gradually decreased. The growth and metastatic capacity of miR-7-resistant human NSCLC cells displaying elevated activation of related signaling pathways were significantly enhanced in vitro and in vivo. Global gene analysis showed that the expression of paired box 6 (PAX6), a target molecule of miR-7, was obviously increased in these cells. Moreover, PAX6 silencing significantly impaired the aggressive behavior of miR-7-resistant human NSCLC cells, accompanied by decreased transduction of the PI3K/AKT pathway. Mechanistically, the histone acetyltransferase KAT8 regulated PAX6 expression via H4K16 acetylation, subsequently resulting in the activation of the PI3K/AKT pathway. Notably, PAX6 silencing significantly improved miR-7 intervention efficiency in human NSCLC cells in vitro and in vivo. Finally, the relatively higher miR-7 expression was correlated with PAX6 expression in clinical NSCLC tumors.ConclusionNSCLC cells acquired resistance to miR-7 intervention, orchestrated by KAT8 regulating PAX6 expression via H4K16 acetylation. Specifically, PAX6 silencing significantly improved miR-7 intervention efficiency in human NSCLC cells, thereby providing a feasible approach for miRNA-based intervention in NSCLC.